Table 1

 Serum concentrations of VEGF-A, TNFα, and ILβ in various connective tissue diseases

Connective tissue diseaseVEGF-A (pg/ml)TNFα (pg/ml)IL1β (pg/ml)
RS3PE syndrome, remitting seronegative symmetrical synovitis with pitting oedema syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; MCTD, mixed connective tissue disease; PM/DM, polymyositis/dermatomyositis.
Data are mean (SD) of the indicated number of patients.
*p<0.0001 v other connective tissue diseases by Student’s t test.
RS3PE syndrome (n = 3)2223.3 (156.3)*26.3 (20.8)0.67 (0.81)
RA (n = 12)711.0 (401.7)19.9 (13.7)0.61 (0.39)
SLE (n = 10)309.9 (140.6)34.2 (19.4)0.32 (0.16)
MCTD (n = 6)682.3 (575.0)51.8 (27.7)0.48 (0.39)
PM/DM (n = 13)324.2 (188.9)22.6 (10.9)0.32 (0.24)
Vasculitis syndrome (n = 13)736.1 (475.5)27.3 (14.2)0.90 (1.38)